Brainsway Ltd. BWAY 深 沪
已收盘 12-12 16:00:00 美东时间
16.965
-0.455
-2.61%
华盛通- 最 高17.52
- 今 开17.52
- 成交量 4.00万股
- 最 低 16.85
- 昨 收 17.42
- 总市值 3.22亿
- 52周最高 18.175
- 市盈率 静 152.43
- 换手率 0.21%
- 52周最低 7.84
- 委 比 0.00%
- 总股本 1900.36万
- 历史最高 18.175
- 量 比 0.71
- 振 幅 3.85%
- 历史最低 1.38
- 每 手 1
- 风险率 2.82%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
12-09 10:32
HC Wainwright & Co. Maintains Buy on BrainsWay, Raises Price Target to $24
HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy and raises the price target from $18 to $24.
12-08 20:37
BrainsWay Initiates Clinical Trial for Alcohol Use Disorder
Brainsway ( ($BWAY) ) has shared an announcement. On November 17, 2025, BrainsW...
11-17 20:58
美股大行评级 | 思科、On Holding、派拓网络等获多家机构上调目标价；Circle 遭富国、德银等多家机构下调目标价
今日重点评级关注：HC Wainwright & Co.：维持PDS Biotechnology"买入"评级，目标价从13美元升至15美元；HC Wainwright & Co.：维持PepGen Inc."买入"评级，目标价从18美元升至20美元
11-14 10:43
美股大行评级 | 富国银行上调AMD目标价升至345美元；花旗上调礼来目标价升至1500美元；巴克莱上调腾讯音乐目标价升至28美元
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从12美元升至15美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从106美元升至107美元
11-13 09:58
Northland Capital Markets Maintains Outperform on BrainsWay, Raises Price Target to $23
Northland Capital Markets analyst Carl Byrnes maintains BrainsWay (NASDAQ:BWAY) with a Outperform and raises the price target from $19 to $23.
11-13 02:07
BrainsWay Raises FY2025 Sales Guidance from $50.000M-$52.000M to $51.000M-$52.000M
BrainsWay (NASDAQ:BWAY) raises FY2025 sales outlook from $50.000 million-$52.000 million to $51.000 million-$52.000 million.
11-11 20:31
BrainsWay Q3 EPS $0.04 Misses $0.07 Estimate, Sales $13.512M Beat $13.041M Estimate
BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.07 by 42.86 percent. This is a 100 percent increase over earnings of $0.02 per share from the same
11-11 20:30
Earnings Scheduled For November 11, 2025
Companies Reporting Before The Bell • Gogoro (NASDAQ:GGR) is estimated to repor...
11-11 19:11
BrainsWay Awarded $2.5M Grant From U.S. NIH To Support Clinical Trial Evaluating Deep Transcranial Magnetic Stimulation Protocol Through BrainsWay's Device For Alcohol Use Disorder Treatment
BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the U.S. National Institutes
11-04 21:09
